Jon David Donshik, MD in Plantation, FL - Medicare Orthopedic Surgery

Jon David Donshik, MD is a medicare enrolled "Orthopaedic Surgery" physician in Plantation, Florida. He went to Perelman School Of Med At The University Of Pennsylvania and graduated in 1994 and has 30 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Ortho Florida, Llc and his current practice location is 301 Nw 84th Ave, Ste 303, Plantation, Florida. You can reach out to his office (for appointments etc.) via phone at (954) 888-1000.

Jon David Donshik is licensed to practice in Florida (license number ME79363) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396748091.

Contact Information

	Jon David Donshik, MD
	301 Nw 84th Ave, Ste 303, Plantation, FL 33324-1807
	(954) 888-1000
	(954) 888-1446

Physician's Profile

Full Name	Jon David Donshik
Gender	Male
Speciality	Orthopedic Surgery
Experience	30 Years
Location	301 Nw 84th Ave, Plantation, Florida
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Jon David Donshik attended and graduated from Perelman School Of Med At The University Of Pennsylvania in 1994

NPI Data:

NPI Number: 1396748091
Provider Enumeration Date: 05/27/2005
Last Update Date: 08/12/2020

Medicare PECOS Information:

PECOS PAC ID: 7416027420
Enrollment ID: I20120423000606

Medical Identifiers

Medical identifiers for Jon David Donshik such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396748091	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	ME79363 (Florida)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Ortho Florida, Llc	3274616453	102

News Archive

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Tris Pharma, Inc. announced that U.S. Food and Drug Administration has accepted for review its New Drug Application ("NDA") for Dyanavel XR (amphetamine) CII, an Extended-Release Oral Suspension.

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

The Associated Press reports that, because many steps remain in the rate setting process, the initial rates announced by insurers do not offer "clarity."

Personal benefit, helping others motivate clinical trial participants

Most HIV-infected individuals participating in a clinical trial hope to benefit personally from the research but also understand they are contributing to society, according to a report in the June 23 issue of Archives of Internal Medicine.

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer, increasing progression-free survival.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jon David Donshik allows following entities to bill medicare on his behalf.

Entity Name	Ortho Florida, Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1821113192 PECOS PAC ID: 3274616453 Enrollment ID: O20080211000758

News Archive

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Tris Pharma, Inc. announced that U.S. Food and Drug Administration has accepted for review its New Drug Application ("NDA") for Dyanavel XR (amphetamine) CII, an Extended-Release Oral Suspension.

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

The Associated Press reports that, because many steps remain in the rate setting process, the initial rates announced by insurers do not offer "clarity."

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Entity Name	Jon D Donshik Md Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1164548889 PECOS PAC ID: 1456512235 Enrollment ID: O20120423000576

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Tris Pharma, Inc. announced that U.S. Food and Drug Administration has accepted for review its New Drug Application ("NDA") for Dyanavel XR (amphetamine) CII, an Extended-Release Oral Suspension.

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

The Associated Press reports that, because many steps remain in the rate setting process, the initial rates announced by insurers do not offer "clarity."

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jon David Donshik is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jon David Donshik, MD 301 Nw 84th Ave, Ste 303, Plantation, FL 33324-1807 Ph: (954) 888-1000	Jon David Donshik, MD 301 Nw 84th Ave, Ste 303, Plantation, FL 33324-1807 Ph: (954) 888-1000

News Archive

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Tris Pharma, Inc. announced that U.S. Food and Drug Administration has accepted for review its New Drug Application ("NDA") for Dyanavel XR (amphetamine) CII, an Extended-Release Oral Suspension.

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

The Associated Press reports that, because many steps remain in the rate setting process, the initial rates announced by insurers do not offer "clarity."

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Orthopaedic Surgery Doctors in Plantation, FL

Dr. Martin E Hale, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 499 Nw 70th Ave, Suite 200, Plantation, FL 33317 Phone: 954-474-3223 Fax: 954-474-3226
Dr. Robert Wells Baylis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 N Pine Island Rd, Suite 200, Plantation, FL 33324 Phone: 954-476-8800 Fax: 954-476-1362
Dr. David A Blum, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 S Pine Island Rd, Suite 300, Plantation, FL 33324 Phone: 954-473-6344 Fax: 954-476-9077
Dr. Fernando Antonio Moya-huff, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1228 S Pine Island Rd Ste 310, Plantation, FL 33324 Phone: 954-392-1725 Fax: 954-837-1113
Dr. Jahangir Asghar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 499 Nw 70th Ave Ste 200, Plantation, FL 33317 Phone: 954-223-5843 Fax: 954-223-5484
Alexandr Aylyarov, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8251 W Broward Blvd Ste 300, Plantation, FL 33324 Phone: 954-724-3400
Mr. Andrew S Ellowitz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4101 Nw 4th St, Suite 305, Plantation, FL 33317 Phone: 954-583-8130 Fax: 954-583-8956

Jon David Donshik, MD - Medicare Orthopedic Surgery in Plantation, FL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Medicare Reassignments

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA accepts Tris Pharma's Dyanavel XR NDA for review

Early rate requests from insurers provide few clues for small businesses attempting to determine costs

Personal benefit, helping others motivate clinical trial participants

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Orthopaedic Surgery Doctors in Plantation, FL